AdvanSix Inc
AdvanSix Inc operates in the Chemicals industry within the Materials sector, generating revenue through the production and sale of chemical products, with significant exposure to specific industrial customers such as Shaw Industries Group Inc.
Business. AdvanSix Inc (ASIX.K) is a chemicals company operating within the Materials sector. The firm is headquartered in the United States and is primarily listed on the New York Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data. Consequently, the company is described at the industry level as a participant in the broader chemicals market.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
AdvanSix Inc (ASIX.K) is a chemicals company operating within the Materials sector. The firm is headquartered in the United States and is primarily listed on the New York Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data. Consequently, the company is described at the industry level as a participant in the broader chemicals market.
AdvanSix maintains a conservative capital structure characterized by a reported debt-to-equity ratio of 0.0, indicating an absence of long-term debt in the latest snapshot. The balance sheet shows total assets of $1.71 billion against total liabilities of $891 million, resulting in total equity of $815 million. Liquidity is supported by cash and equivalents of $19.8 million and operating cash flow of $122.9 million, which comfortably covers capital expenditures of $116.4 million, resulting in positive free cash flow. The risk assessment flags liquidity risk as low, consistent with the strong cash generation relative to investment needs.
Profitability metrics indicate modest returns on capital, with a return on equity (ROE) of 6.05% and a return on assets (ROA) of 2.89%. Net income stands at $49.3 million on revenues of $1.52 billion, implying a net margin of approximately 3.2%. Without cohort median data for direct comparison, these returns suggest a capital-intensive business model typical of the chemicals industry, where margins are often pressured by commodity input costs and cyclical demand. The low debt load provides financial flexibility but also suggests the company may not be leveraging capital to enhance equity returns significantly.
Revenue concentration is a notable feature of the business profile, with Shaw Industries Group Inc. identified as the largest customer, accounting for 10% of sales. This level of customer concentration is within typical thresholds for industrial chemical suppliers but warrants monitoring for any changes in the relationship or demand patterns from this key account. The absence of detailed segment or geographic breakdowns in the current data limits a deeper analysis of diversification, but the reliance on a single named customer highlights the importance of maintaining strong industrial relationships.
Growth trajectory analysis is constrained by the absence of historical period data in the current input. The latest revenue figure of $1.52 billion serves as the baseline for current performance. Without multi-year revenue or net income trends, it is not possible to assess the company's growth momentum or cyclicality from the provided data. The stable share count of 26.9 million shares outstanding suggests no recent significant equity issuances or buybacks in the latest period.
Risk factors are assessed as low for both liquidity and dilution, with no immediate filing-based flags detected. The primary operational risk stems from customer concentration, specifically the 10% revenue dependency on Shaw Industries. The lack of debt eliminates interest rate risk and refinancing pressure, but the company's ability to maintain profitability depends on operational efficiency and market pricing for its chemical products. The low dilution risk is supported by the identical basic and diluted share counts, indicating no significant options or convertible securities impacting the share base.
Recent events include system-level reconciler activities noting zero analysis jobs for the company, which reflects data processing status rather than corporate actions. There are no disclosed news events, filing observations, or transcript observations indicating strategic shifts, mergers, or significant operational changes. The IR observations confirm the customer relationship with Shaw Industries, which remains a key point of interest for investors monitoring revenue stability.
- Debt-free balance sheet with $815 million in equity and $19.8 million in cash provides strong financial flexibility.
- Modest profitability with 6.05% ROE and 2.89% ROA reflects typical chemical industry margins.
- Customer concentration risk exists with Shaw Industries accounting for 10% of sales.
- Positive free cash flow generation as operating cash flow of $122.9 million exceeds capex of $116.4 million.
- Low liquidity and dilution risks with no immediate filing-based flags detected.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Physical assets
1 tracked| Asset | Type | Commodity | Country | Role |
|---|---|---|---|---|
| Hopewell Manufacturing Complex | Chemical plant | Chemicals | United States | Registered owner |
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Return On Equitynet_income / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Return On Assetsnet_income / total_assets
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- AdvanSix Inc. Market data — financials · 2026-07-26
- reconciler_enqueue (reconciler) on ASIX.K · 2026-07-26
- AdvanSix Inc HA canonical relationships · 2026-07-26
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,01 %$27M
- Investment Managers · as of 2026-03-310,01 %$18M
- Investment Managers · as of 2026-03-310,01 %$16M
- Investment Managers · as of 2026-03-310,01 %$32M
- Investment Managers · as of 2026-03-310,00 %$15M
- Investment Managers · as of 2026-03-310,00 %$17M
- Investment Managers · as of 2024-06-300,00 %$110M
- Investment Managers · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$12M
- Investment Managers · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$16M
- Institutional Investor · as of 2026-03-310,00 %$15M
- Investment Managers · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$10M
- Investment Managers · as of 2024-12-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$14M
- Investment Managers · as of 2025-12-310,00 %$30M
- Institutional Investor · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$1M
- Funds · as of 2026-03-310,00 %$2M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Leadership
- Erin N. KanePresident, Chief Executive Officer, Director
- Michael PrestonSenior Vice President
Insider activity
- Director · Common Stock, par value $0.01Other 660 @ $19,88$13K · 2026-06-30
- Director · Common Stock, par value $0.01Other 6 207 · 2026-06-22
- Director · Common Stock, par value $0.01Other 6 207 · 2026-06-22
- Director · Common Stock, par value $0.01Other 6 207 · 2026-06-22
- Director · Common Stock, par value $0.01Other 6 207 · 2026-06-22
- Director · Common Stock, par value $0.01Other 6 207 · 2026-06-22
- Director · Common Stock, par value $0.01Other 6 207 · 2026-06-22
- Director · Common Stock, par value $0.01Other 6 207 · 2026-06-22
- Director · Common Stock, par value $0.01Other 6 207 · 2026-06-22
- SVP, CFO · Common Stock, par value $0.01Other 19 019 @ $23,66$450K · 2026-04-27
- Director · Common Stock, par value $0.01Other 537 @ $24,40$13K · 2026-03-31
- VP, Controller · Common Stock, par value $0.01Other 2 074 @ $22,02$46K · 2026-03-24
- SVP, Chief HR Officer · Common Stock, par value $0.01Other 5 424 @ $17,47$95K · 2026-02-28
- VP and Interim CFO · Common Stock, par value $0.01Other 2 624 @ $17,47$46K · 2026-02-28
- SVP, General Counsel · Common Stock, par value $0.01Other 8 008 @ $17,47$140K · 2026-02-28
- Director, Chief Executive Officer · Common Stock, par value $0.01Other 33 642 @ $17,47$588K · 2026-02-28
- SVP, General Counsel · Common Stock, par value $0.01Other 28 106 @ $17,79$500K · 2026-02-26
- VP, Controller · Common Stock, par value $0.01Other 5 621 @ $17,79$100K · 2026-02-26
- SVP, Chief HR Officer · Common Stock, par value $0.01Other 22 485 @ $17,79$400K · 2026-02-26
- VP and Interim CFO · Common Stock, par value $0.01Other 21 079 @ $17,79$375K · 2026-02-26
- Director, Chief Executive Officer · Common Stock, par value $0.01Other 111 298 @ $17,79$2,0M · 2026-02-26
- Director · Common Stock, par value $0.01Other 821 @ $15,97$13K · 2025-12-15
- Director · Common Stock, par value $0.01Other 1 721 @ $15,97$27K · 2025-12-15
- SVP, General Counsel · Common Stock, par value $0.01Sold 577 @ $20,00$12K · 2025-10-03
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Total assets (annual): USD 1.71BUnknown
- Total liabilities (annual): USD 890.93MUnknown
- Current assets (annual): USD 440.61MUnknown
- Shares outstanding (annual): 26.86MUnknown
- R&D expense (annual): USD 8.7MUnknown
- Net income (annual): USD 49.3MUnknown
- Capex (annual): USD 116.44MUnknown
- Cash & equivalents (annual): USD 19.77MUnknown
- Operating cash flow (annual): USD 122.86MUnknown
- Current liabilities (annual): USD 389.95MUnknown
- EPS (basic) (annual): USD-PER-SHARES 2Unknown
- EPS (diluted) (annual): USD-PER-SHARES 2Unknown
- Shareholders' equity (annual): USD 815.22MUnknown
- Cost of revenue (annual): USD 1.36BUnknown
- Pre-tax income (annual): USD 54.43MUnknown
- Current liabilities (annual): USD 357.1MUnknown
- Capex (annual): USD 133.72MUnknown
- Pre-tax income (annual): USD 45.58MUnknown
- Operating cash flow (annual): USD 135.41MUnknown
- Total assets (annual): USD 1.59BUnknown
- Shares outstanding (annual): 26.74MUnknown
- Cash & equivalents (annual): USD 19.56MUnknown
- Total liabilities (annual): USD 820.27MUnknown
- Current assets (annual): USD 387.12MUnknown